top of page
  • Regulatory House

EMA has recommended first COVID-19 vaccine for childrem aged 12 to 15 in EU!

The European Medicines Agency (EMA) has recommended extending use of Comirnaty to adolescents aged 12 to 15 years. Currently, the use of this vaccine from the Pfizer / BioNTech consortium has been approved from 16 years. Following the EMA's recommendation, a decision on the change will be issued by the European Commission and such a decision will automatically be valid in all EU Member States.

For more see this link.

0 views0 comments

Recent Posts

See All

Which products cannot be registered?

SÚKL has published several types of products on its website for which it is no longer possible to apply for registration as a medicinal product, as they do not meet the definition under Section 2 of A


bottom of page